Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;66(9):931-7.
doi: 10.1001/archgenpsychiatry.2009.113.

Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought

Peter Rabins  1 , Brian S Appleby, Jason Brandt, Mahlon R DeLong, Laura B Dunn, Loes Gabriëls, Benjamin D Greenberg, Suzanne N Haber, Paul E Holtzheimer 3rd, Zoltan Mari, Helen S Mayberg, Evelyn McCann, Sallie P Mink, Steven Rasmussen, Thomas E Schlaepfer, Dorothy E Vawter, Jerrold L Vitek, John Walkup, Debra J H Mathews
Affiliations

Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought

Peter Rabins et al. Arch Gen Psychiatry. 2009 Sep.

Abstract

Context: A 2-day consensus conference was held to examine scientific and ethical issues in the application of deep brain stimulation for treating mood and behavioral disorders, such as major depression, obsessive-compulsive disorder, and Tourette syndrome.

Objectives: The primary objectives of the conference were to (1) establish consensus among participants about the design of future clinical trials of deep brain stimulation for disorders of mood, behavior, and thought and (2) develop standards for the protection of human subjects participating in such studies.

Results: Conference participants identified 16 key points for guiding research in this growing field.

Conclusions: The adoption of the described guidelines would help to protect the safety and rights of research subjects who participate in clinical trials of deep brain stimulation for disorders of mood, behavior, and thought and have further potential to benefit other stakeholders in the research process, including clinical researchers and device manufactures. That said, the adoption of the guidelines will require broad and substantial commitment from many of these same stakeholders.

PubMed Disclaimer

Conflict of interest statement

All other authors report no conflicts of interest or financial disclosures.

References

    1. Appleby BS, Duggan PS, Regenberg A, Rabins PV. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A meta-analysis of ten years' experience. Mov Disord. 2007;22(12):1722–8. - PubMed
    1. Larson PS. Deep brain stimulation for psychiatric disorders. Neurotherapeutics. 2008;5(1):50–8. - PMC - PubMed
    1. Kopell BH, Greenberg BD. Anatomy and physiology of the basal ganglia: Implications for DBS in psychiatry. Neurosci Biobehav Rev. 2008;32(3):408–22. - PubMed
    1. Schlaepfer TE, Lieb K. Deep brain stimulation for treatment of refractory depression. Lancet. 2005;366(9495):1420–2. - PubMed
    1. Gabriels L, Cosyns P, Nuttin B, Demeulemeester H, Gybels J. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases. Acta Psychiatr Scand. 2003;107(4):275–82. - PubMed

Publication types

MeSH terms